1-7 of 7
Graça Esteves
Close
Sort by
Journal Articles

Pomalidomide-Dexamethasone Effectiveness in t(11;14) Positive Relapsed Multiple Myeloma in Real-World Setting

Sudeep Karve, Shaji Kumar, Veronica Gonzalez De La Calle, Silvia Mangiacavalli, Chang-Ki Min, Efstathios Kastritis, Graca Esteves, Michel Delforge, Fernando Escalante, Jin Lu, Yang Liu, Max Bittrich, Charalampia Kyriakou, Andrew J. Yee, Emma Arriola, Jeremy A. Ross, Shivaji Manthena, Brian G.M. Durie
Journal: Blood
Blood (2021) 138 (Supplement 1): 3803.
https://doi.org/10.1182/blood-2021-149336
Published: 2021
Journal Articles

Disseminated Intravascular Coagulation Score Evolution in 48 Hours Predicts Early Death in Newly-Diagnosed Chemotherapy-Treated Acute Promyelocytic Leukemia Patients

Joana Brioso Infante, MD MSc, Graca Esteves, MD, Helena Martins, MD, Julia Medeiros, MD, Daniela Alves, MD, Conceicao Lopes, MD, Maria Joao Costa, MD, Maria Blanca Guerrero, MD, Raul Moreno, MD, Fernanda Lourenço, MD, Carlos Martins, MD, Joao F Lacerda, MD PhD, João Raposo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-143138
Published: 2020
Journal Articles

A Predictive Model for Early Death after Frontline Hypomethylating Agents in Elderly Unfit Acute Myeloid Leukemia Patients: Results from the Pethema Group

Fernando Ramos, David Martinez-Cuadron, Josefina Serrano, Maria Lopez-Pavia, Marta Fuertes-Nuñez, Teresa Bernal, Juan Ignacio Rodriguez-Gutierrez, Isabel Recio, Ana Garrido, Daniel Garcia, Claudia Lucia Sossa, MD, Cristina Gil, Rosario Varela, Pilar Martinez-Sanchez, Maria Angeles Foncillas, Mar Tormo, Antonia Cladera, Graca Esteves, José F. Falantes, Adolfo de la Fuente, Blanca Boluda, Miguel A. Sanz, Pau Montesinos Fernandez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 648.
https://doi.org/10.1182/blood-2019-125053
Published: 2019
Journal Articles

Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study

Shaji K. Kumar, MD, Jin Lu, MDProf, Yang Terry Liu, PhD, Max Bittrich, MD, Juan Du, MD, Hartmut Goldschmidt, MD, Charalampia Kyriakou, MD PhD, Donna E Reece, MD, Kihyun Kim, MD PhD, Maria-Victoria Mateos, Veronica Gonzalez De La Calle, MD PhD, Wenming Chen, MD, Heinz Ludwig, MD, Giampaolo Merlini, MD, Silvia Mangiacavalli, Meletios A. Dimopoulos, MD, Eftathios Kastritis, Chang-Ki Min, MD PhD, Graca Esteves, Andrew J. Yee, MD, Noopur S. Raje, MD, Emily Rosta, Anja Haltner, Chris Cameron, Brian G.M. Durie, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3066.
https://doi.org/10.1182/blood-2019-126867
Published: 2019
Journal Articles

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis

Clinical Trials & Observations
Bruno Paiva, María Victoria Mateos, Luis Ignacio Sanchez-Abarca, Noemi Puig, María-Belén Vidriales, Lucía López-Corral, Luis A. Corchete, Miguel T. Hernandez, Joan Bargay, Felipe de Arriba, Javier de la Rubia, Ana-Isabel Teruel, Pilar Giraldo, Laura Rosiñol, Felipe Prosper, Albert Oriol, José Hernández, Graça Esteves, Juan José Lahuerta, Joan Bladé, Jose Antonio Perez-Simon, Jesús F. San Miguel
Journal: Blood
Blood (2016) 127 (9): 1151–1162.
https://doi.org/10.1182/blood-2015-10-662320
Published: 2016
Includes: Supplemental data
Journal Articles

Low-Dose Dexamethasone Does Not Abrogate the Immunomodulatory Effects of Lenalidomide and Both Reactivate the Impaired Immune System of High-Risk Smoldering Multiple Myeloma Patients

Bruno Paiva, PhD, Maria-Victoria Mateos, Luis Ignacio Sánchez-Abarca, Maria Belen Vidriales, MD PhD, Lucia Lopez-Corral, MD, Luis A Corchete, Miguel T Hernandez, Joan Bargay, MD PhD, Felipe De Arriba, Javier De La Rubia, Ana Isabel Teruel, MD, Pilar Giraldo, MD PhD, Laura Rosiñol, MDPhD, Felipe Prosper, MD, Albert Oriol, MDPhD, Jose Mariano Hernandez, MD, Graça Esteves, Fernando Leal da Costa, Juan Jose Lahuerta, Joan Blade, MDPhD, Jose A. Perez-Simon, MD, PhD, Jesus San Miguel, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2955.
https://doi.org/10.1182/blood.V126.23.2955.2955
Published: 2015
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Graça Esteves, MD, Manuel L Neves, Helena Martins, Carlos M. Martins, MD, Maria Joao Costa, MD, Sara Valle, MD, Conceição Lopes, MD, João Raposo, MD, Lurdes Guerra, MD, Blanca Polo, MD, Ana Alho, Carolina Viveiros, MD, Susana Mendes, Rita Ferreira, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 1873.
https://doi.org/10.1182/blood.V122.21.1873.1873
Published: 2013